Filter Results:
(3,355)
Show Results For
- All HBS Web
(3,355)
- People (4)
- News (757)
- Research (1,742)
- Events (29)
- Multimedia (77)
- Faculty Publications (1,043)
Show Results For
- All HBS Web
(3,355)
- People (4)
- News (757)
- Research (1,742)
- Events (29)
- Multimedia (77)
- Faculty Publications (1,043)
- 22 Apr 2024
- Research & Ideas
When Does Impact Investing Make the Biggest Impact?
The idea of supporting social change has propelled impact investing assets to more than $1 trillion. But what if those funds aren’t as impactful as investors expect? Recent Harvard Business School research indicates that while impact... View Details
Keywords: by Rachel Layne
- 25 Apr 2023
- HBS Seminar
Bart Vanneste, UCL School of Management
- 25 Aug 2021
- News
PRIMO 2021: An Introduction to Research
- Web
Overview - MBA
MS/MBA Biotechnology: Life Sciences Overview Bridging Science and Business Harvard offers a joint degree program that confers an MBA from Harvard View Details
- 19 Apr 2004
- Research & Ideas
Birth of the American Salesman
Walter A. Friedman's new book Birth of a Salesman chronicles the rise and development of modern sales management from the 18th century to the present day. Its fascinating cast of dynamic business figures and academic leaders includes John... View Details
Keywords: by Laura Linard
- 01 Dec 2015
- First Look
December 1, 2015
will have an important future impact on our understanding of consumer psychology. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=50106 forthcoming Management Science Experimental Evidence of Pooling Outcomes Under... View Details
Keywords: Sean Silverthorne
- November 2020
- Case
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage... View Details
Keywords: Mergers and Acquisitions; Value; Valuation; Judgments; Decision Making; Cash Flow; Financial Instruments; Cognition and Thinking; Pharmaceutical Industry; Biotechnology Industry; United States
Esty, Benjamin C., and Daniel Fisher. "Valuing Celgene's CVR." Harvard Business School Case 221-031, November 2020.
- 25 Jul 2023
- Blog Post
Malcolm McClain (MBA/MPP 2023) Named First RISE Career Fellow
Malcolm McClain (MBA/MPP 2023) has been named the first recipient of the Harvard Business School (HBS) RISE (Recognizing Individuals Seeking Equity) Career Fellow, with his income supplemented for one year following graduation so he can... View Details
- 11 Apr 2023
- Research & Ideas
Is Amazon a Retailer, a Tech Firm, or a Media Company? How AI Can Help Investors Decide
estate company—they have a lot of buildings,” says MarcAntonio Awada, head of research and data science at the Digital, Data, and Design Institute at Harvard (D^3). For an investor looking for an edge, the distinction could be critical.... View Details
- Web
Publications - Faculty & Research
Lynn S., and Suraj Srinivasan. "How Robust Is Your Climate Governance?" Harvard Business Review 102, no. 6 (November–December 2024): 86–95. November–December 2024 Article How to Avoid the Agility Trap By: Jianwen Liao and Feng Zhu Agility... View Details
- Web
Curriculum - MBA
curriculum, students build a solid, broad foundation of general management concepts and skills across all the key disciplines. Required Curriculum Data Science for Manager (DSM) Finance 1 (FIN1) Financial Reporting and Control (FRC)... View Details
- 19 Jun 2019
- News
Faculty Books in Brief: Summer 2019
- Web
PhD Programs - Doctoral
PhD Programs The start of your PhD program launches your journey to a career in business academia. Students in our PhD programs are encouraged from day one to think of this experience as their first job in View Details
- Web
Faculty & Research
HBS Book Smart Rivals: How Innovative Companies Play Games That Tech Giants Can't Win By: Feng Zhu and Bonnie Yining Cao In Smart Rivals , Harvard Business School professor Feng Zhu and former Bloomberg journalist Bonnie Yining Cao show... View Details
- March 2009
- Case
Incept LLC and Confluent Surgical (A)
By: Bhaskar Chakravorti, Toby E. Stuart and James Weber
A venture capitalist must decide whether to invest in a medical technology company that licenses intellectual property from a privately held IP holding company based on a platform technology. Entrepreneurs Amar Sawhney and Fred Khosravi founded Incept LLC to... View Details
Keywords: Business Model; Entrepreneurship; Intellectual Property; Rights; Agreements and Arrangements; Partners and Partnerships; Trust; Medical Devices and Supplies Industry
Chakravorti, Bhaskar, Toby E. Stuart, and James Weber. "Incept LLC and Confluent Surgical (A)." Harvard Business School Case 809-062, March 2009.
- Web
Faculty & Advisors - MBA
MS/MBA Biotechnology: Life Sciences Faculty & Advisors Faculty Amitabh Chandra, Ph.D. MS/MBA Program Faculty Co-Chair for MBA Henry and Allison McCance Professor of Business Administration at HBS, Ethel... View Details
- 15 Dec 2015
- First Look
December 15, 2015
monetary rewards are at stake (Study 3). The tendency to infer dislike from dissimilarity is driven by a belief that others have a narrow and homogeneous range of preferences (Study 5). Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=50152 December... View Details
Keywords: Carmen Nobel
- 10 Apr 2007
- First Look
First Look: April 10, 2007
Working PapersNone this week. Cases & Course MaterialsAscent Media Group (A) Harvard Business School Case 607-064 Ascent Media races to adapt to the changes resulting from increasing digitalization of its business, from creative... View Details
Keywords: Martha Lagace
- September 2009 (Revised September 2010)
- Case
Avid Radiopharmaceuticals and Lighthouse Capital Partners
By: Matthew Rhodes-Kropf and Ann Leamon
In fall 2008, a venture lender must decide whether to make a loan to Avid, a small but promising venture-backed life sciences firm. In reviewing her proposal, Cristy Barnes considers the company's characteristics and how they differ from a typical investment. At the... View Details
Keywords: Business Startups; Decision Choices and Conditions; Financial Crisis; Venture Capital; Private Equity; Financing and Loans; Investment; Financial Services Industry; Health Industry
Rhodes-Kropf, Matthew, and Ann Leamon. "Avid Radiopharmaceuticals and Lighthouse Capital Partners." Harvard Business School Case 810-054, September 2009. (Revised September 2010.)
- 04 May 2017
- HBS Seminar